IL-3 R alpha

IL-3 R alpha 분자 정보

영어 이름Interleukin-3 receptor subunit alpha시판 약물 수1
임상 약물 수40표적 별명IL3RY,IL-3RA,CD123 Antigen,IL3RX,IL-3R Subunit Alpha,IL3R,IL-3 Receptor Subunit Alpha,IL-3 Receptor Alpha SP2 Isoform,Interleukin 3 Receptor Subunit Alpha,IL3RAY,IL-3R-Alpha,CD123,HIL-3Ra,IL3RA,Interleukin 3 Receptor, Alpha (Low Affinity),Interleukin-3 Receptor Subunit Alpha,Interleukin-3 Receptor alpha Subunit
최고 연구 개발 단계Approved
영어 이름Interleukin-3 receptor subunit alpha
표적 별명IL3RY,IL-3RA,CD123 Antigen,IL3RX,IL-3R Subunit Alpha,IL3R,IL-3 Receptor Subunit Alpha,IL-3 Receptor Alpha SP2 Isoform,Interleukin 3 Receptor Subunit Alpha,IL3RAY,IL-3R-Alpha,CD123,HIL-3Ra,IL3RA,Interleukin 3 Receptor, Alpha (Low Affinity),Interleukin-3 Receptor Subunit Alpha,Interleukin-3 Receptor alpha Subunit
시판 약물 수1
임상 약물 수40
최고 연구 개발 단계Approved

IL-3 R alpha분자 배경

Interleukin 3 receptor alpha (low affinity) (IL3RA), also known as CD123 (Cluster of Differentiation 123) is a 70-kD glycoprotein member of the hematopoietin receptor superfamily. This protein associates with a beta subunit common to the receptors for IL-5 and granulocyte-macrophage colony-stimulating factor (GM-CSF) to form a high-affinity receptor for IL-3. The interleukin-3 receptor α chain (CD123) has been identified as a potential immunotherapeutic target because it is overexpressed in AML compared with normal hematopoietic stem cells.

IL-3 R alpha분자 별명

IL3R,IL3RA,IL-3Ra,IL-3R-alpha,IL3RAY,IL3RX,IL3RY,CD123 antigen,CD123,hIL3Ra,hIL-3Ra,MGC34174,IL-3 R alpha

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
TalacotuzumabCSL-362; JNJ-473; CSL-362-AML; JNJ-56022473; IL-13 MAb-CSLPhase 2 ClinicalCsl LtdLeukemia, Myeloid, Acute; Myelodysplastic Syndromes
상세
VibecotamabXmAb-14045Phase 2 ClinicalXencor IncBlastic Plasmacytoid Dendritic Cell Neoplasm; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
상세
CD123 CAR-T cell therapy(Chongqing Precision Biotechnology)Phase 2 ClinicalChongqing Precision Biotechnology Co LtdBlastic Plasmacytoid Dendritic Cell Neoplasm; Leukemia; Leukemia, Myeloid; Leukemia, Myeloid, Acute
상세
Anti-CD123 CAR T-cell therapy (Southwest Hospital)Phase 2 ClinicalThe Southwest Hospital of AMULeukemia; Leukemia, Myeloid
상세
CD33-CD123-CLL1 CART-T cell therapy (Hebei Taihe Chunyu Biotechnology)Phase 2 ClinicalHebei Tahoe Chunyu Biotechnology Co LtdLeukemia, Myeloid
상세
CAR-T Cells Targeting CD33/CD123 therapy(Essen Biotech)BAH244; BAH-244Phase 2 ClinicalEssen BiotechLeukemia, Myeloid, Acute
상세
AZD-9829AZD9829; AZD-9829Phase 2 ClinicalAstrazeneca PlcHematologic Diseases; Hematologic Neoplasms; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes
상세
Anti Tim-3/CD123 CAR-T Cell Therapy(Xuzhou Medical University)Phase 2 ClinicalThe Affiliated Hospital Of Xuzhou Medical University, Xuzhou Medical University (Xzmu)Leukemia, Myeloid, Acute
상세
MP0533MP0533Phase 2 ClinicalMolecular Partners AgLeukemia, Myeloid, Acute
상세
MipletamigAPVO-436; APVO436Phase 2 ClinicalAptevoLeukemia, Myeloid, Acute; Myelodysplastic Syndromes
상세
Anti-CD123 CAR T-cell therapy (University of Pennsylvania/Novartis)JEZ-567Phase 1 ClinicalNovartis Pharma Ag, University Of PennsylvaniaLeukemia, Myeloid, Acute
상세
FlotetuzumabS-80880; MGD-006; RES-234Phase 1 ClinicalMacrogenics IncBlastic Plasmacytoid Dendritic Cell Neoplasm; Hematologic Neoplasms; Hodgkin Disease; Leukemia; Leukemia, Biphenotypic, Acute; Leukemia, Hairy Cell; Leukemia, Myelogenous, Chronic; Leukemia, Myeloid, Acute; Mastocytosis, Systemic; Neoplasms, Plasma Cell; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
상세
UCART-123UCART-123; UCART-123v1.2Phase 1 ClinicalCellectis SaBlastic Plasmacytoid Dendritic Cell Neoplasm; Leukemia, Myeloid, Acute
상세
Anti-CD123 CAR T cell therapy (Shanghai GeneChem)Phase 1 ClinicalShanghai Genechem Co LtdLeukemia, Myeloid, Acute
상세
Anti-CD123 CAR T-cell therapy (Nanjing Legend Biotech)Phase 1 ClinicalLeukemia, Myeloid, Acute
상세
MB-102 (Mustang Bio)MB-102Phase 1 ClinicalCity Of Hope National Medical Center, Mustang Bio IncBlastic Plasmacytoid Dendritic Cell Neoplasm; Leukemia, Biphenotypic, Acute; Leukemia, Myeloid, Acute; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma
상세
ACLX-002ACLX-002Phase 1 ClinicalArcellx IncLeukemia, Myeloid, Acute; Myelodysplastic Syndromes
상세
MGD-024MGD-024Phase 1 ClinicalMacrogenics IncBlastic Plasmacytoid Dendritic Cell Neoplasm; Hodgkin Disease; Leukemia, B-Cell; Leukemia, Hairy Cell; Leukemia, Myelogenous, Chronic; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasms
상세
AFM-28AFM-28Phase 1 ClinicalAffimedLeukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Neoplasms
상세
VIP943BAY-943; VIP-943Phase 1 ClinicalBayer AGLeukemia, Myeloid, Acute; Myelodysplastic Syndromes; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
상세
Anti-CD123 LV redirected T cells Therapy (Childrens Hospital of Philadelphia)CART123Phase 1 ClinicalChildrens Hospital of PhiladelphiaLeukemia, Myeloid, Acute
상세
JY-017JY017; JY-017Phase 1 ClinicalInstitute Of Hematology & Blood Diseases HospitalLeukemia, Myeloid, Acute
상세
ACLX-004ACLX-004Phase 1 ClinicalArcellx IncLeukemia, Myeloid, Acute; Myelodysplastic Syndromes
상세
Donor-derived CD123-CD16 bispecific antibody-modified NK cells therapy(Chinese PLA General Hospital)Phase 1 ClinicalPla General HospitalLeukemia, Myeloid, Acute
상세
Autologous CAR123 T lymphocytes cell tharapy(Institute of Hematology and Blood Transfusion, Czech Republic)Phase 1 ClinicalInstitute of Hematology and Blood Transfusion, Czech RepublicBlastic Plasmacytoid Dendritic Cell Neoplasm; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma
상세
Anti-CD123 CAR NK cells therapy(Chongqing Precision Biotechnology)Phase 1 ClinicalChongqing Precision Biotechnology Co LtdLeukemia, Myeloid, Acute; Neoplasms, Plasma Cell
상세
RJK-RT2831RJK-RT2831; RJKRT2831; RT-2831; RT2831Phase 1 ClinicalNanjing RegeneCore Biotech Co LtdHematologic Neoplasms
상세
CD123 CAR-NK cell therapy(Beijing JD Biotech)JD123; JD-123Phase 1 ClinicalBeijing JD Biotech Co LtdLeukemia, Myeloid, Acute
상세
Universal CAR-T Cells therapy(Shenzhen Geno-Immune Medical Institute)Phase 1 ClinicalShenzhen Geno-Immune Medical InstituteLeukemia, Myeloid, Acute
상세
AVC-201AVC-201; Allo-RevCAR01-T-CD123Phase 1 ClinicalAvenCell Europe GmbHLeukemia, Myeloid, Acute
상세
CD123-CAR T cells(St Jude Children's Research Hospital)Phase 1 ClinicalSt. Jude Children'S Research HospitalBlastic Plasmacytoid Dendritic Cell Neoplasm; Myelodysplastic Syndromes; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma
상세
LAVA-1266LAVA1266; LAVA-1266Phase 1 ClinicalLava Therapeutics NVHematologic Neoplasms; Leukemia, Myeloid, Acute
상세
Allogenic CD123-CAR-NK Cells therapy(JD Biotech)JD023Phase 1 ClinicalBeijing JD Biotech Co Ltd, Chinese Academy Of Military Medical SciencesLeukemia, Myeloid, Acute
상세
BYON-4413BYON-4413Phase 1 ClinicalByondis BvHematologic Neoplasms; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes
상세
GR-1901GR1901; GR-1901Phase 1 ClinicalChongqing Genrix Biopharmaceutical Co Ltd, Genrix (Shanghai) Biopharmaceutical Co LtdLeukemia, Myeloid, Acute
상세
SQZ-622(Novartis Pharma)SQZ-622Phase 1 ClinicalNovartis Pharma AgLeukemia, Myeloid, Acute
상세
SAR-443579SAR-443579; SAR443579; SAR'579; IPH6101; IPH-6101Phase 1 ClinicalSanofiBlastic Plasmacytoid Dendritic Cell Neoplasm; Hematologic Diseases; Leukemia, B-Cell; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma
상세
UniCAR02-TUniCAR02-TPhase 1 ClinicalCellex Patient Treatment GmbhBreast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Kidney Neoplasms; Prostatic Neoplasms
상세
IL3 CAR T-cell therapy (Yake Biotechnology)Phase 1 ClinicalZhejiang UniversityLeukemia, Myeloid, Acute
상세
Anti-CD123 chimeric antigen receptor T cell therapy (Yake Biotechnology)ClinicalShanghai YaKe Biotechnology Co LtdLeukemia, Myeloid, Acute
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
TagraxofuspSL-401; DTIL-3; DT388 IL3ApprovedTexas A&M University Development FoundationElzonrisUnited StatesBlastic Plasmacytoid Dendritic Cell NeoplasmStemline Therapeutics Inc2018-12-21Blastic Plasmacytoid Dendritic Cell Neoplasm; Leukemia; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Lymphoma; Multiple Myeloma; Myelodysplastic Syndromes; Primary Myelofibrosis
상세

제품 리뷰

  • A***r2026-03-11
    0사람들이 좋아합니다
    We've always had a pleasure experience with AcroBio. Products are always top quality, quote requests come back super quick, and everyone is very kind. Great, great team to work with!
  • C***e2023-05-23
    0사람들이 좋아합니다
    We used Biotinylated Human IL-3 R alpha / CD123 Protein, Fc,Avitag™ (MALS verified) for a viral titer assay with Jurkat cells and received excellent results. We had a great experience ordering from the Acro biosystems website, which was easy to navigate. The reconstitution directions were very helpful and clear and each vial lasted for several experiments. The shipping was very quick and we look forward to ordering more products from Acro.
  • Y***a2022-05-10
    0사람들이 좋아합니다
    We received the product at a reasonably fast speed. We used this product in ELISA. The product is robust and of good quality. The characterization information was accurate, reliable, and valuable for further calculations.
더 불러오기
  • 분자 정보
  • 제품 목록
  • 시판 약물 정보
  • 제품 리뷰
  • 임상 약물 정보
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호